Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
GenHealth.ai is a specialized generative AI platform designed for the healthcare sector, utilizing a unique Large Medical Model (LMM) developed from the analysis of over 100 million patient records instead of traditional natural language data. This LMM excels in interpreting medical codes and events, allowing it to accurately forecast patient outcomes, estimate costs, and model clinical pathways with significantly fewer errors compared to conventional large language models. The platform features a range of tailored applications such as Intake Automation for managing PDF routing and data extraction, a Prior Authorization Agent that automates the approval process, and G‑Mode analytics that allows users to interact with both historical and predictive population health data using natural language, all without requiring any coding expertise. Notably, this AI co-pilot has achieved an impressive 94% accuracy rate in prior authorization cases, a remarkable 120-fold enhancement in forecasting medical loss ratios, and a 110% improvement in cost predictions when compared to standard Hierarchical Condition Category (HCC) scoring methods. In addition to these advancements, GenHealth.ai is positioned to transform the healthcare landscape by facilitating more efficient and data-driven decision-making.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
API Access
Has API
Integrations
Google Cloud Platform
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
GenHealth.ai
Country
United States
Website
genhealth.ai/
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/
Product Features
Population Health Management (PHM)
Analytics
Cost-of-Care Analysis
Data Storage
EMR/EHR Integration
Patient Engagement
Patient Identification
Patient Risk Stratification
Patient-Reported Outcomes
Payment Bundling
Predictive Alerts
Test & Treatment Reminders
Utilization Tracking